Research Article
The Biological Metallic versus Metallic Solution in Treating Periprosthetic Femoral Fractures: Outcome Assessment
Table 2
Patients’ comorbidity.
| | PS (%) | PSS number (%) |
| Comorbidity | | | Cardiovascular diseases | 6 (75%) | 5 (71.42%) | Stroke | 4 (50%) | 1 (14.29%) | Respiratory diseases | 5 (62.5%) | 6 (85.71%) | Nefro-urologic diseases | 5 (62.5%) | 2 (28.57%) | Diabetes mellitus | 4 (50%) | 6 (85.71%) | Rheumatic diseases | 4 (50%) | 7 (100%) | Parkinson’s disease | 1 (12.5%) | 2 (28.57%) | Smokers | 1 (12.5%) | 3 (42.86%) | Use of steroids | 7 (87.5%) | 7 (100%) | Number of comorbidities for patient | | | 1 | 1 (12.5%) | 1 (14.29%) | 2 | 2 (25%) | 1 (14.29%) | ≥3 | 5 (62.5%) | 5 (71.42%) |
|
|